Back to top

Neurosense Therapeutics Ltd. (NRSN) Gets a Buy from Noble Financial

Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Neurosense Therapeutics Ltd. today and set a price target of $9.00. LeBoyer cover...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: